5 Biotechnology Stocks to Buy Now Dec 25, 2013, 8:00 am EST
This is a strong week for Insmed Incorporated (INSM). The company’s rating climbs to B from the
previous week’s C. Insmed develops and commercializes drugs that treat metabolic diseases, endocrine disorders and oncology. Investors seem to agree with the upgraded status of the stock and have pushed the stock up 5.4% over the past month.